Employing Payloads with Dual MoA to Improve Therapeutic Window of ADC
Time: 1:45 pm
day: Conference Day 2
Details:
- Introducing novel camptothecins with moderate Top1 inhibition, strong anti-tumor potency and improved safety profile
- Comprehending how dual MoA of novel payloads can contribute to improved therapeutic windows
- Investigating applications of dual MoA to improve general safety profiles of ADCs
